Expression of different isoforms of utrophin in human muscle; potentials for therapy of Duchenne muscular dystrophy

Expression of different isoforms of utrophin in human muscle; potentials for therapy of Duchenne muscular dystrophy

書誌詳細
主要な著者:	Sewry, C, Nowak, K, Ehmsen, J, Davies, K
フォーマット:	Conference item
出版事項:	2004

類似資料

Utrophin in the therapy of Duchenne Muscular Dystrophy
著者:: Potter, A, 等
出版事項: (2006)

The role of utrophin in the potential therapy of Duchenne muscular dystrophy.
著者:: Perkins, K, 等
出版事項: (2002)

Utrophin upregulation in Duchenne muscular dystrophy.
著者:: Hirst, R, 等
出版事項: (2005)

The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy
著者:: Guiraud, S, 等
出版事項: (2019)

A and B utrophin in human muscle and sarcolemmal A-utrophin associated with tumours.
著者:: Sewry, C, 等
出版事項: (2005)

Correlation of utrophin levels with the dystrophin protein complex and muscle fibre regeneration in Duchenne and Becker muscular dystrophy muscle biopsies
著者:: Janghra, N, 等
出版事項: (2016)

Metabolic profiles of dystrophin and utrophin expression in mouse models of Duchenne muscular dystrophy.
著者:: Griffin, J, 等
出版事項: (2002)

Identification of new chemical compounds with upregulate utrophin for the therapy of Duchenne muscular dystrophy
著者:: Fairclough, R, 等
出版事項: (2012)

Correlation of Utrophin Levels with the Dystrophin Protein Complex and Muscle Fibre Regeneration in Duchenne and Becker Muscular Dystrophy Muscle Biopsies.
著者:: Narinder Janghra, 等
出版事項: (2016-01-01)

Evaluation of novel compounds for upregulation of utrophin in animal models of Duchenne muscular dystrophy therapy
著者:: Fairclough, R, 等
出版事項: (2008)

New orally available compounds which modulate utrophin expression for the therapy of Duchenne muscular dystrophy (DMD)
著者:: Fairclough, R, 等
出版事項: (2014)

Utrophin in therapy of Duchenne muscular distrophy
著者:: Fisher, R
出版事項: (2001)

Analysis of the transcriptional control of utrophin promoters as a therapeutic strategy for Duchenne muscular dystrophy (DMD).
著者:: Perkins, K, 等
出版事項: (2000)

Discovery of 2-arylbenzoxazoles as upregulators of utrophin production for the treatment of Duchenne muscular dystrophy.
著者:: Chancellor, DR, 等
出版事項: (2011)

Utrophin upregulation and microRNAs - two avenues of Duchenne muscular dystrophy therapy research
著者:: Bareja, A
出版事項: (2011)

Alternative utrophin mRNAs contribute to phenotypic differences between dystrophin-deficient mice and Duchenne muscular dystrophy
著者:: Perkins, K, 等
出版事項: (2018)

Mechanism of action studies of the utrophin modulator ezutromid for the treatment of Duchenne muscular dystrophy
著者:: Wilkinson, I
出版事項: (2019)

Promising therapeutic approaches of utrophin replacing dystrophin in the treatment of Duchenne muscular dystrophy
著者:: Ruo Wu, 等
出版事項: (2022-11-01)

Progress in therapy for Duchenne muscular dystrophy.
著者:: Fairclough, R, 等
出版事項: (2011)

Progress in therapy for Duchenne muscular dystrophy
著者:: Fairclough, R, 等
出版事項: (2011)

The role of basal and myogenic factors in the transcriptional activation of utrophin promoter A: implications for therapeutic up-regulation in Duchenne muscular dystrophy.
著者:: Perkins, K, 等
出版事項: (2001)

Duchenne muscular dystrophy and dystrophin: pathogenesis and opportunities for treatment.
著者:: Nowak, K, 等
出版事項: (2004)

Muscle X-inactivation patterns and dystrophin expression in Duchenne muscular dystrophy carriers.
著者:: Matthews, P, 等
出版事項: (1995)

Future clinical and biomarker development for SMTC1100, the first utrophin modulator to enter clinical trials for Duchenne Muscular Dystrophy (DMD)
著者:: Tinsley, J, 等
出版事項: (2013)

Metabolic dysfunction and altered mitochondrial dynamics in the utrophin-dystrophin deficient mouse model of duchenne muscular dystrophy.
著者:: Meghna Pant, 等
出版事項: (2015-01-01)

Regenerative biomarkers for Duchenne muscular dystrophy
著者:: Guiraud, S, 等
出版事項: (2019)

Duchenne muscular dystrophy - past, present and future
著者:: Davies, K
出版事項: (2002)

From diagnosis to therapy in Duchenne muscular dystrophy
著者:: Babbs, A, 等
出版事項: (2020)

Pharmacological advances for treatment in Duchenne muscular dystrophy
著者:: Guiraud, S, 等
出版事項: (2017)

Cardiac therapies for Duchenne muscular dystrophy
著者:: Md Nur Ahad Shah, 等
出版事項: (2023-07-01)

Rehabilitation therapy of Duchenne muscular dystrophy
著者:: Cheng ZHANG, 等
出版事項: (2012-06-01)

Understanding the endothelial function of utrophin.
著者:: Ehmsen, J, 等
出版事項: (2002)

Duchenne Muscular Dystrophy
著者:: J Gordon Millichap
出版事項: (1989-05-01)

Regenerative biomarkers for Duchenne muscular dystrophy
著者:: Simon Guiraud, 等
出版事項: (2019-01-01)

Therapeutic approaches for Duchenne muscular dystrophy
著者:: Roberts, TC, 等
出版事項: (2023)

Medical management of muscle weakness in Duchenne muscular dystrophy.
著者:: Sarah R Rivera, 等
出版事項: (2020-01-01)

Therapy for Duchenne muscular dystrophy: renewed optimism from genetic approaches.
著者:: Fairclough, R, 等
出版事項: (2013)

Investigating the role of dystrophin isoform deficiency in motor function in Duchenne muscular dystrophy
著者:: Mary Chesshyre, 等
出版事項: (2022-04-01)

Challenges to oligonucleotides-based therapeutics for Duchenne muscular dystrophy.
著者:: Goyenvalle, A, 等
出版事項: (2011)

Nitric Oxide and l-Arginine Cause an Accumulation of Utrophin at the Sarcolemma: A Possible Compensation for Dystrophin Loss in Duchenne Muscular Dystrophy
著者:: Emmanuel Chaubourt, 等
出版事項: (1999-12-01)